Workflow
HOME CONTROL(01747)
icon
Search documents
【真灼港股动向】Home Control 进军家庭医疗健康领域,以获增长
Xin Lang Cai Jing· 2025-08-16 04:02
Core Viewpoint - Home Control International Limited reported strong financial performance for the six months ending June 30, 2025, with significant growth in revenue and net profit, driven by automation and cost management measures [1][2]. Financial Performance - Revenue reached approximately $59.6 million, a year-on-year increase of 14.3% [1]. - Gross profit grew by 14.6% to about $17.7 million [1]. - Net profit for the period was $5.0 million, reflecting a substantial year-on-year increase of 56.9% [1]. - Net profit margin improved from 6.2% in the first half of 2024 to 8.5% in the first half of 2025 [1]. Revenue Contribution - Control solutions accounted for 80.2% of total revenue [1]. - Healthcare solutions grew from approximately 15.5% of total revenue in the first half of 2024 to about 19.7% in the first half of 2025 [1]. Strategic Developments - The company rebranded its "Omni Remotes" to "Omni Devices" to better reflect its expansion into the healthcare sector [2]. - Home Control is focused on developing integrated solutions utilizing AI and IoT for personal health management and seamless healthcare experiences [2][3]. - The CEO emphasized the company's operational efficiency, product innovation, and cash flow management as key strengths in navigating economic challenges [2]. Future Outlook - Home Control is optimistic about its prospects in the AI era, particularly in providing smart home and healthcare solutions [2]. - The company is working with strategic partners to develop a smart healthcare platform powered by advanced AI and blockchain technology [3]. - Continued investment in R&D, sales team expansion, and supply chain optimization is planned to enhance competitive positioning [3].
HOME CONTROL发布中期业绩,股东应占溢利503.4万美元 同比增加56.92%
Zhi Tong Cai Jing· 2025-08-15 13:30
Core Viewpoint - HOME CONTROL (01747) reported a revenue of $59.564 million for the six months ending June 30, 2025, representing a year-on-year increase of 14.31% [1] - The profit attributable to the company's owners was $5.034 million, a year-on-year increase of 56.92%, with earnings per share at 0.99 cents [1] - The company's net profit for the six months ending June 30, 2025, is approximately $5 million, an increase of about 56.3% compared to the net profit of approximately $3.2 million for the same period in 2024 [1] Financial Performance - Revenue for the six months ending June 30, 2025, was $59.564 million, up 14.31% year-on-year [1] - Profit attributable to owners increased to $5.034 million, a rise of 56.92% compared to the previous year [1] - Earnings per share reached 0.99 cents [1] Profitability Measures - The company's net profit for the period is approximately $5 million, reflecting a 56.3% increase from $3.2 million in the same period last year [1] - The growth in profit is attributed to automation, cost management measures, efficiency improvements, and material savings [1]
HOME CONTROL(01747)发布中期业绩,股东应占溢利503.4万美元 同比增加56.92%
智通财经网· 2025-08-15 13:30
Group 1 - The core viewpoint of the article highlights HOME CONTROL's financial performance for the six months ending June 30, 2025, showing a revenue of $59.564 million, a year-on-year increase of 14.31% [1] - The company reported a profit attributable to owners of $5.034 million, reflecting a significant year-on-year increase of 56.92% [1] - Earnings per share for the period were reported at $0.099 [1] Group 2 - The company's net profit for the six months ending June 30, 2025, is approximately $5 million, which is an increase of about 56.3% compared to the net profit of approximately $3.2 million for the same period in 2024 [1] - The growth in profit is attributed to the company's automation and cost management measures, as well as efficiency improvements and material savings [1]
HOME CONTROL(01747) - 2025 - 中期业绩
2025-08-15 13:16
[Interim Results Announcement](index=1&type=section&id=Interim%20Results%20Announcement) [Board Announcement](index=1&type=section&id=Board%20Announcement) The Board announces the Group's unaudited interim results for the six months ended June 30, 2025, with comparative figures - The company announced its unaudited condensed consolidated interim results for the six months ended June 30, 2025[3](index=3&type=chunk) [Unaudited Condensed Consolidated Financial Statements](index=2&type=section&id=Unaudited%20Condensed%20Consolidated%20Financial%20Statements) [Unaudited Condensed Consolidated Statement of Comprehensive Income](index=2&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Comprehensive%20Income) Revenue grew 14.3% to $59,564 thousand, with profit for the period increasing significantly by 56.9% to $5,034 thousand **Key Financial Performance for the Six Months Ended June 30** | Metric | 2025 (USD thousands) | 2024 (USD thousands) | Change (%) | | :--- | :--- | :--- | :--- | | Revenue | 59,564 | 52,107 | 14.3% | | Cost of sales | (41,872) | (36,668) | 14.2% | | Gross profit | 17,692 | 15,439 | 14.6% | | Profit before tax | 6,433 | 4,106 | 56.7% | | Income tax expense | (1,399) | (898) | 55.8% | | Profit for the period | 5,034 | 3,208 | 56.9% | | Basic earnings per share (US cents) | 0.99 | 0.63 | 57.1% | | Diluted earnings per share (US cents) | 0.99 | 0.63 | 57.1% | [Unaudited Condensed Consolidated Statement of Financial Position](index=3&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Financial%20Position) Total assets slightly increased to $69,091 thousand, while net current assets and total equity grew, reflecting profit growth **Key Financial Position as of Period End** | Metric | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | Change (%) | | :--- | :--- | :--- | :--- | | Total assets | 69,091 | 68,491 | 0.9% | | Total non-current assets | 11,311 | 11,356 | -0.4% | | Total current assets | 57,780 | 57,135 | 1.1% | | Total current liabilities | 39,650 | 42,808 | -7.4% | | Net current assets | 18,130 | 14,327 | 26.5% | | Net assets | 28,896 | 25,173 | 14.8% | | Total equity | 28,896 | 25,173 | 14.8% | [Notes to the Unaudited Condensed Consolidated Financial Information](index=5&type=section&id=Notes%20to%20the%20Unaudited%20Condensed%20Consolidated%20Financial%20Information) [1. Company and Group Information](index=5&type=section&id=1.%20Company%20and%20Group%20Information) The company is an investment holding company providing sensing and control solutions for smart home and consumer electronics markets - The company is an investment holding company, primarily engaged in providing sensing and control technology solutions for the smart home automation, consumer electronics, and set-top box markets[7](index=7&type=chunk) - The company's shares were listed on the Main Board of the Stock Exchange on November 14, 2019[8](index=8&type=chunk) [2. Basis of Preparation](index=5&type=section&id=2.%20Basis%20of%20Preparation) The interim financial information is prepared in accordance with IAS 34 and should be read with the 2024 annual financial statements - The financial information is prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting"[10](index=10&type=chunk) - Management's significant judgments in applying accounting policies and key sources of estimation uncertainty were the same as those applied to the consolidated financial statements for the year ended December 31, 2024[10](index=10&type=chunk) [3. Changes in Accounting Policies and Disclosures](index=6&type=section&id=3.%20Changes%20in%20Accounting%20Policies%20and%20Disclosures) The Group's accounting policies are consistent with the previous year, except for new standards effective January 1, 2025 - The Group has adopted new standards and amendments effective for the accounting period beginning January 1, 2025[13](index=13&type=chunk) - The adoption of these new standards and amendments is not expected to have a significant impact on the Group's results or financial position for the current or prior years[13](index=13&type=chunk) [4. Operating Segment Information](index=6&type=section&id=4.%20Operating%20Segment%20Information) The Group operates as a single reportable segment, with revenue growth in Europe and Asia offsetting a decline in North America - The Group has only one reportable operating segment[15](index=15&type=chunk) [(a) External Customer Revenue](index=7&type=section&id=(a)%20External%20Customer%20Revenue) Revenue from Europe and Asia grew by 28.4% and 87.5% respectively, while North American revenue declined by 18.9% **Revenue from External Customers by Geographical Location** | Region | 2025 (USD thousands) | 2024 (USD thousands) | Change (%) | | :--- | :--- | :--- | :--- | | North America | 17,605 | 21,713 | -18.9% | | Europe | 26,018 | 20,259 | 28.4% | | Asia | 12,868 | 6,864 | 87.5% | | Latin America | 3,073 | 3,271 | -6.1% | | **Total** | **59,564** | **52,107** | **14.3%** | [(b) Non-current Assets](index=7&type=section&id=(b)%20Non-current%20Assets) Total non-current assets were $2,215 thousand, primarily located in Asia, with a notable increase in European assets **Non-current Assets by Geographical Location** | Region | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | | :--- | :--- | :--- | | North America | 10 | 20 | | Europe | 201 | 82 | | Asia | 2,004 | 2,177 | | **Total** | **2,215** | **2,279** | [Information on Major Customers](index=7&type=section&id=Information%20on%20Major%20Customers) Two major customers each accounted for over 10% of total revenue, with income from both increasing during the period **Revenue from Major Customers** | Customer | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Customer 1 | 12,510 | 10,822 | | Customer 2 | 9,775 | 7,191 | [5. Revenue and Other Income](index=8&type=section&id=5.%20Revenue%20and%20Other%20Income) Revenue was primarily from sales of goods, with growth in both control and healthcare solutions, while other income was stable **Revenue Analysis** | Revenue Source | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Sales of goods - Control solutions | 47,742 | 43,995 | | Sales of goods - Healthcare solutions | 11,725 | 8,051 | | Patent income | 97 | 61 | | **Total revenue from contracts with customers** | **59,564** | **52,107** | - Revenue from the sale of goods is recognised when control of the goods is transferred, while patent income is recognised over time[21](index=21&type=chunk)[23](index=23&type=chunk) **Other Income Analysis** | Other Income Source | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Government grants | 28 | 32 | | Interest income | 26 | 15 | | Others | – | – | | **Total** | **47** | **54** | [6. Profit Before Tax](index=9&type=section&id=6.%20Profit%20Before%20Tax) Profit before tax was impacted by changes in inventory costs, reduced restructuring expenses, and increased employee benefits **Key Items Deducted from/Credited to Profit Before Tax** | Item | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Cost of inventories sold | 35,969 | 30,612 | | Provision for inventories | 88 | 459 | | Outsourcing costs | 4,881 | 4,617 | | Depreciation of property, plant and equipment | 587 | 679 | | Depreciation of right-of-use assets | 201 | 264 | | Restructuring and severance costs | 10 | 545 | | Employee benefit expenses (wages and salaries) | 5,344 | 5,080 | | Research and development expenses | 2,251 | 2,866 | [7. Finance Costs – Net](index=10&type=section&id=7.%20Finance%20Costs%20%E2%80%93%20Net) Net finance costs decreased to $211 thousand, mainly due to a significant reduction in interest on bank borrowings **Net Finance Costs Analysis** | Item | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Interest on bank borrowings | 113 | 567 | | Interest on lease liabilities | 19 | 12 | | Amortisation of loan arrangement, financing and legal fees | 79 | 33 | | Gain on modification of financial assets | – | (199) | | **Total** | **211** | **413** | - The decrease in net finance costs was primarily due to a reduction in interest on bank borrowings of approximately **$0.4 million**[65](index=65&type=chunk) [8. Income Tax](index=10&type=section&id=8.%20Income%20Tax) Total income tax expense increased due to higher profit before tax, despite a subsidiary benefiting from a lower preferential tax rate - Suzhou Ouqing Electronics Co, Ltd enjoyed a preferential income tax rate of **5% in 2025**, compared to 25% in 2024[28](index=28&type=chunk) **Major Components of Income Tax Expense** | Item | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Current tax – Singapore | 1,366 | 761 | | Current tax – United States | 39 | 96 | | Current tax – China and other regions | 33 | 141 | | Deferred tax (credit) | (7) | (101) | | **Total tax expense for the period** | **1,399** | **898** | [9. Earnings Per Share](index=11&type=section&id=9.%20Earnings%20Per%20Share) Basic and diluted earnings per share both increased to 0.99 US cents from 0.63 US cents in the prior period **Basis for Earnings Per Share Calculation** | Metric | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Profit attributable to owners of the Company | 5,034 | 3,208 | | Weighted average number of ordinary shares in issue | 506,650,000 | 506,650,000 | - Basic and diluted earnings per share were **0.99 US cents**, an increase of 57.1% from 0.63 US cents in the prior year period[4](index=4&type=chunk)[69](index=69&type=chunk) - Diluted earnings per share was the same as basic earnings per share as there were no potential dilutive ordinary shares outstanding[33](index=33&type=chunk) [10. Trade Receivables](index=12&type=section&id=10.%20Trade%20Receivables) Net trade receivables increased to $29,897 thousand, with the majority of balances aged within 90 days **Trade Receivables and Ageing Analysis** | Item | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | | :--- | :--- | :--- | | Trade receivables | 30,112 | 23,790 | | Impairment | (215) | (215) | | **Net amount** | **29,897** | **23,575** | | **Ageing analysis:** | | | | 0 to 90 days | 29,168 | 20,240 | | 91 to 180 days | 527 | 2,130 | | Over 180 days | 202 | 1,205 | - Trade receivables are non-interest-bearing and are generally on credit terms of 30 to 90 days[34](index=34&type=chunk) [11. Trade Payables](index=13&type=section&id=11.%20Trade%20Payables) Trade payables slightly increased to $29,721 thousand, with most balances settled within a 90-day credit period **Trade Payables and Ageing Analysis** | Item | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | | :--- | :--- | :--- | | Trade payables | 29,721 | 28,656 | | **Ageing analysis:** | | | | 0 to 90 days | 21,790 | 21,158 | | 91 to 180 days | 7,855 | 7,446 | | Over 180 days | 76 | 52 | - Trade payables are non-interest-bearing and are normally settled on 90-day credit terms[36](index=36&type=chunk) [12. Cash and Cash Equivalents](index=13&type=section&id=12.%20Cash%20and%20Cash%20Equivalents) Cash and cash equivalents decreased to $14,473 thousand, with balances primarily denominated in USD, EUR, and GBP **Cash and Cash Equivalents** | Currency | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | | :--- | :--- | :--- | | USD | 9,442 | 11,204 | | EUR | 1,334 | 898 | | SGD | 212 | 888 | | RMB | 1,389 | 4,670 | | GBP | 1,708 | 1,475 | | BRL | 214 | 141 | | Others | 174 | 167 | | **Total** | **14,473** | **19,443** | - The Renminbi is not freely convertible but can be exchanged through authorised banks, with remittance subject to PRC foreign exchange controls[38](index=38&type=chunk) [13. Financial Assets Measured at Amortised Cost](index=14&type=section&id=13.%20Financial%20Assets%20Measured%20at%20Amortised%20Cost) The net balance of financial assets at amortised cost was zero, as the unlisted investment was fully impaired **Financial Assets at Amortised Cost** | Item | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | | :--- | :--- | :--- | | Unlisted investment | 3,437 | 3,437 | | Less: Loss allowance | (3,437) | (3,437) | | **Net amount** | **–** | **–** | - The investment, a principal-protected wealth management product, has experienced a significant increase in credit risk with uncertainty in redemption[39](index=39&type=chunk)[40](index=40&type=chunk) [14. Interest-bearing Bank Borrowings](index=14&type=section&id=14.%20Interest-bearing%20Bank%20Borrowings) The Group fully repaid its interest-bearing bank borrowings, reducing the balance from $6,171 thousand to zero **Interest-bearing Bank Borrowings** | Item | June 30, 2025 (USD thousands) | December 31, 2024 (USD thousands) | | :--- | :--- | :--- | | Loans from banks – secured | – | 6,171 | - Bank borrowings were fully repaid during the period; the prior year's balance was a secured loan at SOFR + 2.5%[41](index=41&type=chunk)[42](index=42&type=chunk) [15. Dividends](index=15&type=section&id=15.%20Dividends) No interim dividend was declared for the period, while the final dividend for FY2024 was approved for payment in August 2025 - No dividend was proposed for the six months ended June 30, 2025[89](index=89&type=chunk) - The proposed final dividend of **$1,267 thousand for FY2024** was approved and will be paid on or about August 22, 2025[45](index=45&type=chunk) [Management Discussion and Analysis](index=16&type=section&id=Management%20Discussion%20and%20Analysis) [Overview](index=16&type=section&id=Overview) The Group is a leading home control solutions provider that has expanded into the healthcare sector under the new "Omni Devices" brand - The Group is a leading global provider of home control solutions with over **200 invention patents**[46](index=46&type=chunk)[48](index=48&type=chunk) - The brand was upgraded to **"Omni Devices"**, and the healthcare solutions segment's revenue contribution grew from 15.5% to **19.7%**[49](index=49&type=chunk) - The company was acquired by healthcare holding company Meta-Wisdom Tech Limited, which will accelerate healthcare solution development and the creation of a health monitoring ecosystem[50](index=50&type=chunk) [Business Review](index=17&type=section&id=Business%20Review) The Group's revenue increased by 14.3% to approximately $59.6 million, with net profit growing significantly by 56.3% - Revenue was approximately **$59.6 million**, a 14.3% increase from $52.1 million in the prior year period[52](index=52&type=chunk) - Net profit was approximately **$5.0 million**, a 56.3% increase from $3.2 million, mainly due to automation and optimised cost management[52](index=52&type=chunk) [Prospects and Outlook](index=17&type=section&id=Prospects%20and%20Outlook) The Group will focus on cost management, R&D, and developing AIoT-based healthcare solutions amid geopolitical and trade uncertainties - While global inflation is easing, geopolitical instability and trade policy changes create business uncertainty[53](index=53&type=chunk) - The Group will continue cost management measures, increase R&D investment, expand its sales team, and focus on the home healthcare sector[54](index=54&type=chunk) - It is committed to developing integrated AIoT solutions and platforms to promote healthy home environments and personal health management[54](index=54&type=chunk) [Revenue](index=18&type=section&id=Revenue_MDA) Revenue grew 14.3% to $59.6 million, driven by an $11.8 million increase in Asia and Europe, offsetting a $4.3 million decline elsewhere - Total revenue increased by **14.3% (approximately $7.5 million)**, primarily driven by an increase in revenue from Asia and Europe of approximately $11.8 million[55](index=55&type=chunk) **Revenue by Customer Geographical Location** | Region | 2025 (USD thousands) | 2024 (USD thousands) | Change (USD thousands) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | North America | 17,605 | 21,713 | (4,108) | (18.9) | | Europe | 26,018 | 20,259 | 5,759 | 28.4 | | Asia | 12,868 | 6,864 | 6,004 | 87.5 | | Latin America | 3,073 | 3,271 | (198) | (6.1) | | **Total** | **59,564** | **52,107** | **7,457** | **14.3** | [Cost of Sales](index=18&type=section&id=Cost%20of%20Sales) Cost of sales was $41.9 million, representing 70.3% of total revenue, remaining stable compared to the prior period **Cost of Sales Breakdown** | Item | 2025 (USD thousands) | % of Total | 2024 (USD thousands) | % of Total | | :--- | :--- | :--- | :--- | :--- | | Component costs | 36,058 | 86.1 | 31,069 | 84.7 | | Outsourcing | 4,881 | 11.7 | 4,617 | 12.6 | | Recurring expenses | 933 | 2.2 | 982 | 2.7 | | **Total** | **41,872** | **100.0** | **36,668** | **100.0** | - The cost of sales as a percentage of total revenue slightly decreased from 70.4% to **70.3%**[57](index=57&type=chunk) [Gross Profit](index=19&type=section&id=Gross%20Profit) Gross profit increased by $2.3 million to $17.7 million, primarily driven by higher revenue - Gross profit increased by approximately **$2.3 million to $17.7 million**, mainly due to the increase in revenue[60](index=60&type=chunk) [Other Income](index=19&type=section&id=Other%20Income_MDA) Other income remained stable at approximately $0.1 million compared to the same period last year - Other income was approximately **$0.1 million**, remaining at the same level as the prior year period[61](index=61&type=chunk) [Selling and Distribution Expenses](index=19&type=section&id=Selling%20and%20Distribution%20Expenses) Selling and distribution expenses increased to $3.9 million, mainly due to higher salaries and distribution costs - Selling and distribution expenses increased by approximately **$0.3 million to $3.9 million**, mainly due to an increase in salaries and wages of approximately $0.2 million and distribution expenses of approximately $0.1 million[62](index=62&type=chunk) [Administrative Expenses](index=19&type=section&id=Administrative%20Expenses) Administrative expenses decreased slightly to $5.8 million, primarily due to a reduction in non-capitalised fixed assets - Administrative expenses decreased by approximately **$0.1 million to $5.8 million**, mainly due to a decrease in non-capitalised fixed assets[63](index=63&type=chunk) [Other Expenses](index=20&type=section&id=Other%20Expenses) Other expenses decreased to $1.4 million, driven by significantly lower restructuring costs and reduced exchange differences - Other expenses decreased by approximately **$0.1 million**, mainly due to a decrease in restructuring expenses of approximately $0.5 million and other factors, partially offset by an increase in legal expenses of $0.9 million[64](index=64&type=chunk) [Finance Costs – Net](index=20&type=section&id=Finance%20Costs%20%E2%80%93%20Net_MDA) Net finance costs decreased by approximately $0.2 million, primarily due to lower interest on bank loans - Net finance costs decreased by approximately **$0.2 million**, mainly due to a decrease in interest on bank loans of approximately $0.4 million[65](index=65&type=chunk) [Profit Before Tax](index=20&type=section&id=Profit%20Before%20Tax_MDA) Profit before tax increased to $6.4 million from $4.1 million, reflecting the combined effect of changes in income and expenses - Profit before tax was approximately **$6.4 million**, an increase from $4.1 million in the prior year period[66](index=66&type=chunk) [Income Tax Expense](index=20&type=section&id=Income%20Tax%20Expense) Income tax expense rose to $1.4 million from $0.9 million, primarily as a result of higher profit before tax - Income tax expense increased to approximately **$1.4 million**, mainly due to the increase in profit before tax[67](index=67&type=chunk) [Profit for the Period](index=20&type=section&id=Profit%20for%20the%20Period) Net profit after tax for the period was approximately $5.0 million, an increase of $1.8 million from the prior year - Net profit after tax was approximately **$5.0 million**, an increase of approximately $1.8 million from $3.2 million in the prior year period[68](index=68&type=chunk) [Earnings Per Share](index=20&type=section&id=Earnings%20Per%20Share_MDA) Basic and diluted earnings per share both increased to 0.99 US cents from 0.63 US cents in the prior period - Basic and diluted earnings per share were **0.99 US cents**, compared to 0.63 US cents in the prior year period[69](index=69&type=chunk) [Liquidity and Capital Resources](index=21&type=section&id=Liquidity%20and%20Capital%20Resources) The Group maintained a solid financial position with cash and cash equivalents of approximately $14.5 million - Cash and cash equivalents were approximately **$14.5 million**[70](index=70&type=chunk) - The Board believes the Group's financial position is sound, with sufficient resources to support its operations and foreseeable capital expenditures[70](index=70&type=chunk) [Cash Flow](index=21&type=section&id=Cash%20Flow) The period saw a net cash decrease of $5.4 million, resulting from operating inflows offset by investing and financing outflows **Cash Flow Summary** | Item | 2025 (USD thousands) | 2024 (USD thousands) | | :--- | :--- | :--- | | Net cash from operating activities | 1,658 | 5,507 | | Net cash used in investing activities | (676) | (159) | | Net cash used in financing activities | (6,345) | (2,654) | | Net decrease/(increase) in cash and cash equivalents | (5,363) | 2,694 | | Cash and cash equivalents at end of period | 14,473 | 19,423 | [Net Cash from Operating Activities](index=21&type=section&id=Net%20Cash%20from%20Operating%20Activities) Net cash from operating activities was approximately $1.7 million, driven by cash generated from operations before working capital changes - Net cash from operating activities was approximately **$1.7 million**, primarily contributed by cash generated from operations before working capital changes of approximately $7.5 million[72](index=72&type=chunk) - This was positively impacted by a decrease in inventories and an increase in trade payables, but offset by an increase in trade receivables and income tax paid[72](index=72&type=chunk) [Net Cash Used in Investing Activities](index=22&type=section&id=Net%20Cash%20Used%20in%20Investing%20Activities) Net cash used in investing activities was approximately $0.7 million, mainly for the purchase of property, plant and equipment - Net cash used in investing activities was approximately **$0.7 million**, primarily attributable to the purchase of property, plant and equipment[73](index=73&type=chunk) [Net Cash Used in Financing Activities](index=22&type=section&id=Net%20Cash%20Used%20in%20Financing%20Activities) Net cash used in financing activities was approximately $6.3 million, primarily for the repayment of interest-bearing bank borrowings - Net cash used in financing activities was approximately **$6.3 million**, mainly attributable to the repayment of interest-bearing bank borrowings of approximately $6.3 million[74](index=74&type=chunk) [Net Current Assets](index=22&type=section&id=Net%20Current%20Assets) Net current assets increased by approximately $3.8 million to $18.1 million, driven by higher receivables and lower borrowings - Net current assets increased by approximately **$3.8 million to $18.1 million**[75](index=75&type=chunk) - The increase was mainly due to a rise in trade receivables of approximately $6.3 million and a decrease in interest-bearing loans of approximately $6.2 million[75](index=75&type=chunk) [Capital Expenditure](index=22&type=section&id=Capital%20Expenditure) Capital expenditure for the period was approximately $0.7 million, funded primarily by cash from operating activities - Capital expenditure for the period was approximately **$0.7 million** for the acquisition of property, plant and equipment[76](index=76&type=chunk) - Capital expenditure was mainly funded by cash generated from operating activities[76](index=76&type=chunk) [Capital and Investment Commitments](index=22&type=section&id=Capital%20and%20Investment%20Commitments) As of June 30, 2025, the Group had no significant capital and investment commitments contracted but not recognised - As of June 30, 2025, the Group did not have any significant capital and investment expenditures contracted but not recognised[77](index=77&type=chunk) [Bank Borrowings and Contingent Liabilities](index=22&type=section&id=Bank%20Borrowings%20and%20Contingent%20Liabilities) The Group had no short-term bank borrowings and no significant contingent liabilities as of June 30, 2025 [Bank Borrowings](index=22&type=section&id=Bank%20Borrowings) The Group's short-term bank borrowings were reduced to zero from $6.2 million in the previous year - As of June 30, 2025, the Group's short-term bank borrowings were approximately **zero** (2024: $6.2 million)[78](index=78&type=chunk) [Contingent Liabilities](index=23&type=section&id=Contingent%20Liabilities) As of June 30, 2025, the Group had no significant contingent liabilities and guarantees - As of June 30, 2025, the Group did not have any significant contingent liabilities and guarantees[79](index=79&type=chunk) [Gearing Ratio](index=23&type=section&id=Gearing%20Ratio) The gearing ratio decreased significantly to approximately 0.9% from 11.2% at the end of 2024, indicating lower financial leverage - The gearing ratio decreased from approximately **11.2%** as of December 31, 2024 to approximately **0.9%** as of June 30, 2025[80](index=80&type=chunk) [Future Plans for Material Investments and Capital Assets](index=23&type=section&id=Future%20Plans%20for%20Material%20Investments%20and%20Capital%20Assets) As of June 30, 2025, the Group had no other plans for material investments or capital assets - As of June 30, 2025, the Group had no other plans for material investments or capital assets[81](index=81&type=chunk) [Material Investments, Acquisitions and Disposals of Subsidiaries and Associates](index=23&type=section&id=Material%20Investments,%20Acquisitions%20and%20Disposals%20of%20Subsidiaries%20and%20Associates) The Group made no material investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures during the period - During the period, the Group held no other material investments and had no material acquisitions or disposals of subsidiaries, associates, and joint ventures[82](index=82&type=chunk) [Foreign Exchange Risk Management](index=23&type=section&id=Foreign%20Exchange%20Risk%20Management) The Group manages foreign exchange risk through natural hedging and does not currently use derivative financial instruments - The Group's functional currency is the US dollar, with sales primarily denominated in USD and purchases in USD or RMB[83](index=83&type=chunk) - The Group has not entered into any hedging agreements for its exchange rate risk, as operating results are partially mitigated by a natural hedge[83](index=83&type=chunk) - Management will continue to monitor foreign exchange risk and take prudent measures to minimise currency conversion risks[83](index=83&type=chunk) [Other Information](index=24&type=section&id=Other%20Information) [Employees and Remuneration Policy](index=24&type=section&id=Employees%20and%20Remuneration%20Policy) The Group had 143 employees with total benefit expenses of approximately $6.5 million, utilizing a performance-based remuneration policy - As of June 30, 2025, the Group had **143 employees**, and employee benefit expenses were approximately **$6.5 million**[84](index=84&type=chunk) - The remuneration policy is based on individual performance, competence, market comparables, and Group performance, and is reviewed regularly to attract and retain talent[84](index=84&type=chunk) - All 5,016,337 awarded shares under the Share Award Scheme have been fully vested, with no new shares granted during the period[84](index=84&type=chunk) [Off-balance Sheet Commitments and Arrangements](index=25&type=section&id=Off-balance%20Sheet%20Commitments%20and%20Arrangements) As of the date of this announcement, the Group had not entered into any off-balance sheet transactions - As of the date of this announcement, the Group had not entered into any off-balance sheet transactions[85](index=85&type=chunk) [Use of Proceeds from Listing](index=25&type=section&id=Use%20of%20Proceeds%20from%20Listing) Of the $10.83 million net proceeds from the IPO, $8.11 million has been utilized, with the remainder allocated until late 2027 - The net proceeds from the initial public offering were approximately **HK$84.93 million (approximately US$10.83 million)**[86](index=86&type=chunk) **Use of Proceeds from Initial Public Offering** | Planned Use | Planned Use (USD millions) | Utilised as of June 30, 2025 (USD millions) | Unutilised as of June 30, 2025 (USD millions) | | :--- | :--- | :--- | :--- | | Repayment of bank borrowings | 2.69 | 2.69 | – | | Expansion of professional sales team | 1.76 | 1.37 | 0.39 | | Expansion of supply chain outside China | 0.84 | 0.84 | – | | Working capital and general corporate purposes | 0.70 | – | 2.33 | | Subscription for principal-protected wealth management products | 4.84 | 3.21 | – | | **Total** | **10.83** | **8.11** | **2.72** | - The unutilised proceeds from the IPO are expected to be fully used by December 31, 2027[87](index=87&type=chunk) [Interim Dividend](index=27&type=section&id=Interim%20Dividend) No dividend was proposed for the six months ended June 30, 2025 - No dividend was proposed for the six months ended June 30, 2025[89](index=89&type=chunk) [Post Balance Sheet Events](index=27&type=section&id=Post%20Balance%20Sheet%20Events) No significant events requiring disclosure or adjustment have occurred since the balance sheet date - As of the date of this announcement, no significant events affecting the Company and its subsidiaries that would require additional disclosure or adjustment have occurred[90](index=90&type=chunk) [Corporate Governance Code](index=27&type=section&id=Corporate%20Governance%20Code) The Group is committed to high standards of corporate governance and has complied with all applicable code provisions - The Group has adopted corporate governance policies no less exacting than the Corporate Governance Code and has complied with all applicable code provisions[91](index=91&type=chunk) - The Board will continue to review and improve corporate governance practices to enhance shareholder returns[92](index=92&type=chunk) [Review of Financial Information by Audit Committee](index=27&type=section&id=Review%20of%20Financial%20Information%20by%20Audit%20Committee) The Audit Committee has reviewed the Group's unaudited interim results and discussed financial reporting matters with management - The Audit Committee has reviewed the Group's interim results and discussed accounting principles, risk management, and internal controls with management[93](index=93&type=chunk) - The interim financial information has been reviewed by the Company's auditor in accordance with International Standard on Review Engagements 2410[93](index=93&type=chunk) [Purchase, Sale or Redemption of the Company’s Listed Securities](index=28&type=section&id=Purchase,%20Sale%20or%20Redemption%20of%20the%20Company%E2%80%99s%20Listed%20Securities) Neither the Company nor its subsidiaries purchased, sold, or redeemed any of the Company's listed securities during the period - During the period, neither the Company nor any of its subsidiaries purchased, sold, or redeemed any of the Company's listed securities[94](index=94&type=chunk) [Publication of Interim Results and Despatch of Interim Report](index=28&type=section&id=Publication%20of%20Interim%20Results%20and%20Despatch%20of%20Interim%20Report) The interim results announcement is available on the websites of the Stock Exchange and the Company - The interim results announcement has been published on the websites of the Stock Exchange and the Company[95](index=95&type=chunk) - The interim report containing all information required by the Listing Rules will be published on the said websites in due course[95](index=95&type=chunk) [Definitions](index=28&type=section&id=Definitions) This section provides definitions for key terms used throughout the report, including company names, rules, and currency units - This section provides definitions for key terms used in the report, such as "the Company," "the Group," and "Listing Rules"[96](index=96&type=chunk)[97](index=97&type=chunk)[100](index=100&type=chunk) [Board of Directors](index=30&type=section&id=Board%20of%20Directors) The Board of Directors comprises two executive Directors, two non-executive Directors, and three independent non-executive Directors - The Board of Directors consists of two executive Directors, two non-executive Directors, and three independent non-executive Directors[99](index=99&type=chunk)
HOME CONTROL(01747) - 董事名单与其角色和职能
2025-08-06 13:09
獨立非執行董事 Werner Peter VAN ECK先 生 陳壽康博士 Keet Yee LAI女 士 Home Control International Limited(「本公司」)董事會(「董事會」)成 員 載 列 如 下: 執行董事 蕭國雄先生 (行 政 總 裁) 楊豪放先生 非執行董事 Alain PERROT先 生 (董 事 會 主 席) 馬鷹女士 HOME CONTROL INTERNATIONAL LIMITED 共 設 有 三 個 董 事 委 員 會。董 事 委 員 會 的 組 成 如 下 所 示: 審核委員會 陳壽康博士 (主 席) Werner Peter VAN ECK先 生 Keet Yee LAI女 士 (「本 公 司」) (於 開 曼 群 島 註 冊 成 立 的 有 限 公 司) (股 份 代 號:1747) 薪酬委員會 董事名單與其角色和職能 陳壽康博士 (主 席) Werner Peter VAN ECK先 生 馬鷹女士 提名委員會 Werner Peter VAN ECK先 生 (主 席) Alain PERROT先 生 Keet Yee LAI女 士 香 港,二 零 ...
HOME CONTROL(01747) - 联合公告(1)英皇企业融资有限公司代表要约人就收购HOM...
2025-08-06 10:56
香港交易及結算所有限公司及香港聯合交易所有限公司對本聯合公告的內容 概 不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 就 因 本 聯合公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承 擔 任 何 責 任。 本 聯 合 公 告 僅 供 參 考,並 不 構 成 收 購、購 買 或 認 購 本 公 司 證 券 的 邀 請 或 要 約。 Meta-Wisdom Tech Limited (於 英 屬 處 女 群 島 註 冊 成 立 的 有 限 公 司) Home Control International Limited (於 開 曼 群 島 註 冊 成 立 的 有 限 公 司) (股 份 代 號:1747) 聯合公告 (1)英皇企業融資有限公司 代表要約人 就收購HOME CONTROL INTERNATIONAL LIMITED的 全部已發行股份 (要 約 人 已 擁 有 或 同 意 收 購 者 除 外) 作 出 的 無 條 件 強 制 性 現 金 要 約 截 止; (2)要 約 結 果; (3)結 算 要 約; (4)本 公 司 公 眾 ...
HOME CONTROL(01747) - 截至2025年7月31日之股份发行人的证券变动月报表
2025-08-06 06:20
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: Home Control International Limited (於開曼群島註冊成立的有限公司) 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01747 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.01 USD | | 50,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 5,000,000,000 | USD | | 0.01 USD ...
HOME CONTROL(01747.HK)将于8月15日举行董事会会议以审批中期业绩
Ge Long Hui· 2025-08-05 10:10
格隆汇8月5日丨HOME CONTROL(01747.HK)公告,公司将于2025年8月15日举行董事会会议,藉以 (其中包括)考虑及通过公司及其附属公司截至2025年6月30日止六个月的中期业绩及其发布,及派发 中期股息(如有),以及处理其他事项。 ...
HOME CONTROL(01747) - 董事会会议日期
2025-08-05 10:02
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示 概 不 就 因 本 公 告 全 部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 HOME CONTROL INTERNATIONAL LIMITED (於 開 曼 群 島 註 冊 成 立 的 有 限 公 司) (股 份 代 號:1747) 董事會會議日期 Home Control International Limited(「本公司」)董 事(「董 事」)會(「董事會」)謹 此 宣 佈, 本公司將於二零二五年八月十五日(星 期 五)舉 行 董 事 會 會 議,藉 以(其 中 包 括) 考慮及通過本公司及其附屬公司截至二零二五年六月三十日止六個月之中期 業 績 及 其 發 佈,及 派 發 中 期 股 息(如 有),以 及 處 理 其 他 事 項。 承董事會命 Home Control International Limited 行政總裁兼執行董事 蕭國雄 香 港,二 零 二 五 年 八 月 五 日 於 本 公 告 日 期,董 事 ...
HOME CONTROL(01747) - 截至2025年7月31日之股份发行人的证券变动月报表
2025-08-04 08:14
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致:香港交易及結算所有限公司 公司名稱: Home Control International Limited (於開曼群島註冊成立的有限公司) 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01747 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.01 USD | | 50,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 5,000,000,000 | USD | | 0.01 USD | | 50,000,000 | 本月底法定/註冊 ...